In 2023 we launched our bold new five-year strategy 'On a Mission', we knew it was ambitious, but achievable. Today we’ve published our Annual Report and Accounts 2024, and it’s clear the year marks a ...

NICE has approved the use of the drug fruquintinib (Fruzaqla) for eligible advanced bowel cancer patients living in England and Wales.

The results of the Cancer Prevention Project 3 (CaPP3) trial, a study changing how we think about aspirin and cancer prevention for people with Lynch syndrome.

Bowel cancer is rising fast in under-50s. We're helping drive UK and global research to understand why — and what we can do to stop it.

The NCCNN Education Advisory Group is committed to working collaboratively to support colorectal cancer nurses, raising their voices and ensuring their essential contributions are recognised. Through ...

To mark Lynch Syndrome Awareness Day, we sat down to chat with our supporter, Jane Ashford. We reflected on her own journey and discussed Lynch syndrome care.

Low anterior resection syndrome is a collection of bowel symptoms that can happen after surgery to remove all or part of your rectum.

On Thursday, during a Westminster Hall debate on the merits of a cancer strategy, the UK Government have announced that they will publish a National Cancer Plan for England; fulfilling a long-held ...

Natalie was diagnosed with stage 4 bowel cancer in March 2023. Read her story.

Pelvic exenteration is a major operation that takes out some or all of the organs inside the pelvis. Find out more.

Matt was diagnosed with stage 3 bowel cancer at the age of 39. Read his story.

Mr Jones, lead investigator for a trial looking at giving personalised cancer vaccines to people with bowel cancer, tells us more about this new treatment.